OTLK Outlook Therapeutics, Inc.

NASDAQ
$0.64

Outlook Therapeutics, Inc. (OTLK) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 4 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
7
10 transactions
Insiders selling
0
0 transactions
Purchases
$7.9M
12,003,058 shares
Sales
$0
0 shares
Net activity
$7.9M
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 14, 2026 , by KENYON LAWRENCE A .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
KENYON LAWRENCE A Chief Financial Officer Buy 101,010 $0.00 $0 106,956
Jahr Robert Charles Chief Executive Officer Buy 151,515 $0.00 $0 151,515
Buy 2,525,252 $0.99 $2.5M 24,617,320
Sukhtian Faisal Ghiath Director Buy 95,398 $1.05 $100.0K 220,972
Haddadin Yezan Munther Director Buy 29,000 $0.83 $24.1K 66,167
Buy 8,539,709 $0.59 $5.0M 22,092,068
Sukhtian Faisal Ghiath Director Buy 122,174 $0.41 $50.0K 125,574
HILZINGER KURT J Director Buy 400,000 $0.44 $176.5K 423,655
Haddadin Yezan Munther Director Buy 34,000 $0.44 $15.0K 37,167
THURMAN RANDY H Director Buy 5,000 $0.43 $2.1K 5,593

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.